<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37652559</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2056-5933</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>RMD open</Title><ISOAbbreviation>RMD Open</ISOAbbreviation></Journal><ArticleTitle>Preconception clinical factors related to adverse pregnancy outcomes in patients with systemic lupus erythematosus or primary Sj&#xf6;gren's syndrome: a retrospective cohort study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e003439</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/rmdopen-2023-003439</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To identify preconception clinical factors associated with adverse pregnancy outcomes (APO) in patients with systemic lupus erythematosus (SLE) or primary Sj&#xf6;gren's syndrome (pSS).</AbstractText><AbstractText Label="METHODS">A single-centre, retrospective cohort study was conducted, which included pregnant women treated at the University Medical Center Groningen between January 2010 and August 2021 who fulfilled classification criteria for SLE or pSS. Demographic data, relevant comorbidities, disease duration, disease activity before and during pregnancy, APO, laboratory parameters and treatment regimens were recorded. Associations between the presence of APO and preconception characteristics were evaluated.</AbstractText><AbstractText Label="RESULTS">Our study population included 48 (70%) SLE and 21 (30%) pSS pregnancies concerning 70 fetuses (one twin). Preterm birth (n=9, 19%) was the most frequent APO in SLE pregnancies, while in pSS pregnancies this was miscarriages (n=3, 14%). There were no associations between the presence of APO in SLE pregnancies and clinical parameters, laboratory parameters or medication use prior to conception. In the pSS group, significant associations were found between the presence of APO and body mass index (p=0.010), parity (p=0.046), C4 (p=0.021) and low C4 levels (p=0.002).</AbstractText><AbstractText Label="CONCLUSIONS">No preconception risk factors related to APO were found in SLE pregnancies, whereas preconception complement levels were associated with APO development in patients with pSS.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fierro</LastName><ForeName>Juan J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Microbiolog&#xed;a y Parasitolog&#xed;a, Grupo Reproduccion, Universidad de Antioquia UdeA, Medellin, Antioquia, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prins</LastName><ForeName>Jelmer R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Obstetrics and Gynecology, University Medical Center Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verstappen</LastName><ForeName>Gwenny M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bootsma</LastName><ForeName>Hendrika</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Westra</LastName><ForeName>Johanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Leeuw</LastName><ForeName>Karina</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-0218-9364</Identifier><AffiliationInfo><Affiliation>Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands k.de.leeuw@umcg.nl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>RMD Open</MedlineTA><NlmUniqueID>101662038</NlmUniqueID><ISSNLinking>2056-5933</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011256" MajorTopicYN="N">Pregnancy Outcome</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D047928" MajorTopicYN="Y">Premature Birth</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012859" MajorTopicYN="Y">Sjogren's Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antiphospholipid Syndrome</Keyword><Keyword MajorTopicYN="N">Lupus Erythematosus, Systemic</Keyword><Keyword MajorTopicYN="N">Sjogren's Syndrome</Keyword></KeywordList><CoiStatement>Competing interests: The authors declare that there is no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>31</Day><Hour>20</Hour><Minute>44</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37652559</ArticleId><ArticleId IdType="pmc">PMC10476138</ArticleId><ArticleId IdType="doi">10.1136/rmdopen-2023-003439</ArticleId><ArticleId IdType="pii">rmdopen-2023-003439</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bundhun PK, Soogund MZS, Huang F. Impact of systemic lupus erythematosus on maternal and fetal outcomes following pregnancy: A meta-analysis of studies published between years 2001-2016. J Autoimmun 2017;79:17&#x2013;27. 10.1016/j.jaut.2017.02.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2017.02.009</ArticleId><ArticleId IdType="pubmed">28256367</ArticleId></ArticleIdList></Reference><Reference><Citation>Elliott B, Spence AR, Czuzoj-Shulman N, et al. . Effect of Sjogren&#x2019;s syndrome on maternal and neonatal outcomes of pregnancy. J Perinat Med 2019;47:637&#x2013;42. 10.1515/jpm-2019-0034</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/jpm-2019-0034</ArticleId><ArticleId IdType="pubmed">31287800</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuppa AA, Riccardi R, Frezza S, et al. . Neonatal lupus: follow-up in infants with anti-SSA/Ro antibodies and review of the literature. Autoimmun Rev 2017;16:427&#x2013;32. 10.1016/j.autrev.2017.02.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2017.02.010</ArticleId><ArticleId IdType="pubmed">28212920</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain V, Gordon C. Managing pregnancy in inflammatory Rheumatological diseases. Arthritis Res Ther 2011;13:206. 10.1186/ar3227</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar3227</ArticleId><ArticleId IdType="pmc">PMC3157639</ArticleId><ArticleId IdType="pubmed">21371350</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xf6;rner T, Furie R. Novel paradigms in systemic lupus erythematosus. Lancet 2019;393:2344&#x2013;58. 10.1016/S0140-6736(19)30546-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)30546-X</ArticleId><ArticleId IdType="pubmed">31180031</ArticleId></ArticleIdList></Reference><Reference><Citation>Buyon JP, Kim MY, Salmon JE. Predictors of pregnancy outcomes in patients with lupus. Ann Intern Med 2016;164:131. 10.7326/L15-0500</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/L15-0500</ArticleId><ArticleId IdType="pubmed">26784479</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroese SJ, Abheiden CNH, Blomjous BS, et al. . Maternal and perinatal outcome in women with systemic lupus erythematosus: A retrospective Bicenter cohort study. J Immunol Res 2017;2017:8245879. 10.1155/2017/8245879</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/8245879</ArticleId><ArticleId IdType="pmc">PMC5637847</ArticleId><ArticleId IdType="pubmed">29094052</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyakis S, Lockshin MD, Atsumi T, et al. . International consensus statement on an update of the classification criteria for definite Antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295&#x2013;306. 10.1111/j.1538-7836.2006.01753.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2006.01753.x</ArticleId><ArticleId IdType="pubmed">16420554</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons-Estel GJ, Andreoli L, Scanzi F, et al. . The Antiphospholipid syndrome in patients with systemic lupus erythematosus. J Autoimmun 2017;76:10&#x2013;20. 10.1016/j.jaut.2016.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2016.10.004</ArticleId><ArticleId IdType="pubmed">27776934</ArticleId></ArticleIdList></Reference><Reference><Citation>Pregnolato F, Gerosa M, Raimondo MG, et al. . EUREKA algorithm predicts obstetric risk and response to treatment in women with different Subsets of anti-phospholipid antibodies. Rheumatology 2021;60:1114&#x2013;24. 10.1093/rheumatology/keaa203</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keaa203</ArticleId><ArticleId IdType="pubmed">32441742</ArticleId></ArticleIdList></Reference><Reference><Citation>Brito-Zer&#xf3;n P, Baldini C, Bootsma H, et al. . Sj&#xf6;gren syndrome. Nat Rev Dis Primers 2016;2:16047. 10.1038/nrdp.2016.47</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2016.47</ArticleId><ArticleId IdType="pubmed">27383445</ArticleId></ArticleIdList></Reference><Reference><Citation>Upala S, Yong WC, Sanguankeo A. Association between primary Sjogren&#x2019;s syndrome and pregnancy complications: a systematic review and meta-analysis. Clin Rheumatol 2016;35:1949&#x2013;55. 10.1007/s10067-016-3323-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-016-3323-9</ArticleId><ArticleId IdType="pubmed">27271701</ArticleId></ArticleIdList></Reference><Reference><Citation>De Carolis S, Salvi S, Botta A, et al. . The impact of primary Sjogren's syndrome on pregnancy outcome: our series and review of the literature. Autoimmun Rev 2014;13:103&#x2013;7. 10.1016/j.autrev.2013.09.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2013.09.003</ArticleId><ArticleId IdType="pubmed">24044939</ArticleId></ArticleIdList></Reference><Reference><Citation>Priori R, Gattamelata A, Modesti M, et al. . Outcome of pregnancy in Italian patients with primary Sjogren syndrome. J Rheumatol 2013;40:1143&#x2013;7. 10.3899/jrheum.121518</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.121518</ArticleId><ArticleId IdType="pubmed">23729805</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreoli L, Bertsias GK, Agmon-Levin N, et al. . EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and Menopause in patients with systemic lupus erythematosus and/or Antiphospholipid syndrome. Ann Rheum Dis 2017;76:476&#x2013;85. 10.1136/annrheumdis-2016-209770</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2016-209770</ArticleId><ArticleId IdType="pmc">PMC5446003</ArticleId><ArticleId IdType="pubmed">27457513</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan EM, Cohen AS, Fries JF, et al. . The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271&#x2013;7. 10.1002/art.1780251101</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780251101</ArticleId><ArticleId IdType="pubmed">7138600</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochberg MC. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725. 10.1002/art.1780400928</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780400928</ArticleId><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M, Orbai A-M, Alarc&#xf3;n GS, et al. . Derivation and validation of the systemic lupus International collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis &amp; Rheumatism 2012;64:2677&#x2013;86. 10.1002/art.34473</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.34473</ArticleId><ArticleId IdType="pmc">PMC3409311</ArticleId><ArticleId IdType="pubmed">22553077</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiboski CH, Shiboski SC, Seror R, et al. . American college of rheumatology/European League against rheumatism classification criteria for primary Sjogren&#x2019;s syndrome: A consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol 2017;69:35&#x2013;45. 10.1002/art.39859</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39859</ArticleId><ArticleId IdType="pmc">PMC5650478</ArticleId><ArticleId IdType="pubmed">27785888</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, et al. . Research electronic data capture (Redcap)--A Metadata-driven methodology and Workflow process for providing Translational research Informatics support. J Biomed Inform 2009;42:377&#x2013;81. 10.1016/j.jbi.2008.08.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2008.08.010</ArticleId><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Meissner Y, Fischer-Betz R, Andreoli L, et al. . EULAR recommendations for a core data set for pregnancy registries in rheumatology. Ann Rheum Dis 2021;80:49&#x2013;56. 10.1136/annrheumdis-2020-218356</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-218356</ArticleId><ArticleId IdType="pmc">PMC7788063</ArticleId><ArticleId IdType="pubmed">33055080</ArticleId></ArticleIdList></Reference><Reference><Citation>Bombardier C, Gladman DD, Urowitz MB, et al. . Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis &amp; Rheumatism 1992;35:630&#x2013;40. 10.1002/art.1780350606</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780350606</ArticleId><ArticleId IdType="pubmed">1599520</ArticleId></ArticleIdList></Reference><Reference><Citation>Seror R, Ravaud P, Bowman SJ, et al. . EULAR Sjogren&#x2019;s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren&#x2019;s syndrome. Ann Rheum Dis 2010;69:1103&#x2013;9. 10.1136/ard.2009.110619</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2009.110619</ArticleId><ArticleId IdType="pmc">PMC2937022</ArticleId><ArticleId IdType="pubmed">19561361</ArticleId></ArticleIdList></Reference><Reference><Citation>Seror R, Bowman SJ, Brito-Zeron P, et al. . EULAR Sj&#xf6;gren&#x2019;s syndrome disease activity index (ESSDAI): a user guide. RMD Open 2015;1:e000022. 10.1136/rmdopen-2014-000022</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/rmdopen-2014-000022</ArticleId><ArticleId IdType="pmc">PMC4613159</ArticleId><ArticleId IdType="pubmed">26509054</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordijn SJ, Beune IM, Thilaganathan B, et al. . Consensus definition of fetal growth restriction: a Delphi procedure. Ultrasound Obstet Gynecol 2016;48:333&#x2013;9. 10.1002/uog.15884</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/uog.15884</ArticleId><ArticleId IdType="pubmed">26909664</ArticleId></ArticleIdList></Reference><Reference><Citation>Gestational Hypertension and Preeclampsia . ACOG practice Bulletin, number 222. Obstet Gynecol. 2020. Available: https://journals.lww.com/greenjournal/Fulltext/2020/06000/Gestational_Hypertension_and_Preeclampsia__ACOG.46.aspx</Citation><ArticleIdList><ArticleId IdType="pubmed">32443079</ArticleId></ArticleIdList></Reference><Reference><Citation>Tektonidou MG, Andreoli L, Limper M, et al. . EULAR recommendations for the management of Antiphospholipid syndrome in adults. Ann Rheum Dis 2019;78:1296&#x2013;304. 10.1136/annrheumdis-2019-215213</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2019-215213</ArticleId><ArticleId IdType="pubmed">31092409</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravelli ACJ, Eskes M, van der Post JAM, et al. . Decreasing trend in Preterm birth and perinatal mortality, do disparities also decline BMC Public Health 2020;20:783. 10.1186/s12889-020-08925-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-020-08925-w</ArticleId><ArticleId IdType="pmc">PMC7249399</ArticleId><ArticleId IdType="pubmed">32456627</ArticleId></ArticleIdList></Reference><Reference><Citation>Clowse MEB, Magder LS, Witter F, et al. . Early risk factors for pregnancy loss in lupus. Obstet Gynecol 2006;107(2 Pt 1):293&#x2013;9. 10.1097/01.AOG.0000194205.95870.86</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.AOG.0000194205.95870.86</ArticleId><ArticleId IdType="pubmed">16449114</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M. Pregnancy and systemic lupus erythematosus. Best Pract Res Clin Obstet Gynaecol 2020;64:24&#x2013;30. 10.1016/j.bpobgyn.2019.09.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpobgyn.2019.09.002</ArticleId><ArticleId IdType="pubmed">31677989</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim MY, Buyon JP, Guerra MM, et al. . Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and Antiphospholipid antibodies: results of the PROMISSE study. Am J Obstet Gynecol 2016;214:108. 10.1016/j.ajog.2015.09.066</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2015.09.066</ArticleId><ArticleId IdType="pmc">PMC4698098</ArticleId><ArticleId IdType="pubmed">26432463</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer-Pickel K, Stern C, Eberhard K, et al. . Angiogenic factors in pregnancies of women with Antiphospholipid syndrome and systemic lupus erythematosus. J Reprod Immunol 2018;127:19&#x2013;23. 10.1016/j.jri.2018.04.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jri.2018.04.002</ArticleId><ArticleId IdType="pubmed">29689494</ArticleId></ArticleIdList></Reference><Reference><Citation>Frederiksen LE, Ernst A, Brix N, et al. . Risk of adverse pregnancy outcomes at advanced maternal age. Obstet Gynecol 2018;131:457&#x2013;63. 10.1097/AOG.0000000000002504</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AOG.0000000000002504</ArticleId><ArticleId IdType="pubmed">29420406</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravelli ACJ, Tromp M, Eskes M, et al. . Ethnic differences in Stillbirth and early neonatal mortality in the Netherlands. J Epidemiol Community Health 2011;65:696&#x2013;701. 10.1136/jech.2009.095406</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jech.2009.095406</ArticleId><ArticleId IdType="pmc">PMC3129515</ArticleId><ArticleId IdType="pubmed">20719806</ArticleId></ArticleIdList></Reference><Reference><Citation>Mankee A, Petri M, Magder LS. Lupus anticoagulant, disease activity and low complement in the first trimester are predictive of pregnancy loss. Lupus Sci Med 2015;2:e000095. 10.1136/lupus-2015-000095</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2015-000095</ArticleId><ArticleId IdType="pmc">PMC4680586</ArticleId><ArticleId IdType="pubmed">26688740</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiramatsu Y, Isoda K, Kotani T, et al. . Pre-pregnancy serum complement C3 level is a Predictor of Preterm birth for pregnancies with systemic lupus erythematosus. Arthritis Res Ther 2021;23:140. 10.1186/s13075-021-02522-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-021-02522-x</ArticleId><ArticleId IdType="pmc">PMC8114516</ArticleId><ArticleId IdType="pubmed">33980284</ArticleId></ArticleIdList></Reference><Reference><Citation>Clowse MEB, Wallace DJ, Weisman M, et al. . Predictors of Preterm birth in patients with mild systemic lupus erythematosus. Ann Rheum Dis 2013;72:1536&#x2013;9. 10.1136/annrheumdis-2012-202449</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2012-202449</ArticleId><ArticleId IdType="pubmed">23361085</ArticleId></ArticleIdList></Reference><Reference><Citation>Abramson SB, Buyon JP. Activation of the complement pathway: comparison of normal pregnancy, Preeclampsia, and systemic lupus erythematosus during pregnancy. Am J Reprod Immunol 1992;28:183&#x2013;7. 10.1111/j.1600-0897.1992.tb00787.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0897.1992.tb00787.x</ArticleId><ArticleId IdType="pubmed">1285875</ArticleId></ArticleIdList></Reference><Reference><Citation>Crisafulli F, Andreoli L, Zucchi D, et al. . Variations of C3 and C4 before and during pregnancy in systemic lupus erythematosus: association with disease flares and obstetric outcomes. J Rheumatol 2023:jrheum. 10.3899/jrheum.2022-1135</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.2022-1135</ArticleId><ArticleId IdType="pubmed">37127323</ArticleId></ArticleIdList></Reference><Reference><Citation>Fierro JJ, Vel&#xe1;squez M, Cadavid AP, et al. . Effects of anti-beta 2-glycoprotein 1 antibodies and its association with pregnancy-related morbidity in Antiphospholipid syndrome. Am J Reprod Immunol 2022;87:e13509. 10.1111/aji.13509</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aji.13509</ArticleId><ArticleId IdType="pmc">PMC9285810</ArticleId><ArticleId IdType="pubmed">34738282</ArticleId></ArticleIdList></Reference><Reference><Citation>Marziale A, Bettacchioli E, Picart G, et al. . Antiphospholipid autoantibody detection is important in all patients with systemic autoimmune diseases. J Autoimmun 2020;115:102524. 10.1016/j.jaut.2020.102524</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2020.102524</ArticleId><ArticleId IdType="pubmed">32693965</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim MY, Guerra MM, Kaplowitz E, et al. . Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or Antiphospholipid antibodies. Ann Rheum Dis 2018;77:549&#x2013;55. 10.1136/annrheumdis-2017-212224</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2017-212224</ArticleId><ArticleId IdType="pmc">PMC6037302</ArticleId><ArticleId IdType="pubmed">29371202</ArticleId></ArticleIdList></Reference><Reference><Citation>Cort&#xe9;s-Hern&#xe1;ndez J, Ordi-Ros J, Paredes F, et al. . Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatology (Oxford) 2002;41:643&#x2013;50. 10.1093/rheumatology/41.6.643</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/41.6.643</ArticleId><ArticleId IdType="pubmed">12048290</ArticleId></ArticleIdList></Reference><Reference><Citation>Roubertou Y, Mainbourg S, Hot A, et al. . Cryoglobulinemia in systemic lupus erythematosus: a retrospective study of 213 patients. Arthritis Res Ther 2022;24:167. 10.1186/s13075-022-02857-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-022-02857-z</ArticleId><ArticleId IdType="pmc">PMC9281087</ArticleId><ArticleId IdType="pubmed">35836280</ArticleId></ArticleIdList></Reference><Reference><Citation>Brito-Zer&#xf3;n P, Izmirly PM, Ramos-Casals M, et al. . The clinical spectrum of autoimmune congenital heart block. Nat Rev Rheumatol 2015;11:301&#x2013;12. 10.1038/nrrheum.2015.29</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2015.29</ArticleId><ArticleId IdType="pmc">PMC5551504</ArticleId><ArticleId IdType="pubmed">25800217</ArticleId></ArticleIdList></Reference><Reference><Citation>Izmirly PM, Costedoat-Chalumeau N, Pisoni CN, et al. . Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus. Circulation 2012;126:76&#x2013;82. 10.1161/CIRCULATIONAHA.111.089268</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.111.089268</ArticleId><ArticleId IdType="pmc">PMC3437628</ArticleId><ArticleId IdType="pubmed">22626746</ArticleId></ArticleIdList></Reference><Reference><Citation>Balevic SJ, Weiner D, Clowse MEB, et al. . Hydroxychloroquine PK and exposure-response in pregnancies with lupus: the importance of adherence for neonatal outcomes. Lupus Sci Med 2022;9:e000602. 10.1136/lupus-2021-000602</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2021-000602</ArticleId><ArticleId IdType="pmc">PMC8744126</ArticleId><ArticleId IdType="pubmed">34996856</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Zhang T, Guo Z, et al. . The efficiency of hydroxychloroquine for the treatment of primary Sj&#xf6;gren&#x2019;s syndrome: A systematic review and meta-analysis. Front Pharmacol 2021;12:693796. 10.3389/fphar.2021.693796</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.693796</ArticleId><ArticleId IdType="pmc">PMC8475756</ArticleId><ArticleId IdType="pubmed">34588979</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>